EP on EP Episode 88: Sudden Cardiac Death Trials - Past and Future with Jeanne E. Poole, MD, FHRS-EP on EP Episode 88: Sudden Cardiac Death Trials - Past and Future with Jeanne E. Poole, MD, FHRS

EP on EP Episode 88: Sudden Cardiac Death Trials - Past and Future with Jeanne E. Poole, MD, FHRS

Video Transcription

Video Summary

In this episode of EP on EP, Dr. Jeannie Poole discusses the need for new trials in sudden cardiac death prevention. She highlights the changes in patient care and heart failure medications that have occurred since the old trials and emphasizes the importance of identifying patients at risk. Dr. Poole also debates the role of newer agents, such as Entresto and SGLT2 inhibitors, and the need for further trials to support their use in current guidelines. Furthermore, she discusses the role of scarred myocardium as a predictor of sudden cardiac death and expresses concern about boutique diseases, such as mitral valve prolapse, and the challenges they pose for trial design.

Keywords

sudden cardiac death prevention

patient care

heart failure medications

Entresto

risk identification